Chlorine in PDB 8zfq: Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13
Protein crystallography data
The structure of Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13, PDB code: 8zfq
was solved by
J.Shang,
D.J.Kojetin,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
51.02 /
2.49
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
92.637,
61.775,
119.133,
90,
102.38,
90
|
R / Rfree (%)
|
23.1 /
30.4
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13
(pdb code 8zfq). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13, PDB code: 8zfq:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 8zfq
Go back to
Chlorine Binding Sites List in 8zfq
Chlorine binding site 1 out
of 4 in the Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl502
b:82.7
occ:1.00
|
CL20
|
A:PLB502
|
0.0
|
82.7
|
1.0
|
C16
|
A:PLB502
|
1.8
|
68.9
|
1.0
|
C15
|
A:PLB502
|
2.7
|
78.2
|
1.0
|
C17
|
A:PLB502
|
2.8
|
71.6
|
1.0
|
CE
|
A:MET334
|
3.0
|
56.6
|
1.0
|
CE
|
A:MET364
|
3.2
|
77.2
|
1.0
|
CB
|
A:MET364
|
3.7
|
80.8
|
1.0
|
CB
|
A:LYS367
|
3.8
|
66.5
|
1.0
|
CD2
|
A:LEU330
|
4.0
|
65.0
|
1.0
|
C14
|
A:PLB502
|
4.0
|
77.5
|
1.0
|
CG
|
A:LYS367
|
4.1
|
74.5
|
1.0
|
C18
|
A:PLB502
|
4.1
|
69.4
|
1.0
|
CE2
|
A:PHE368
|
4.1
|
60.1
|
1.0
|
O
|
A:MET364
|
4.2
|
72.5
|
1.0
|
CG
|
A:MET364
|
4.3
|
82.8
|
1.0
|
CA
|
A:MET364
|
4.4
|
86.1
|
1.0
|
CD2
|
A:PHE368
|
4.5
|
61.9
|
1.0
|
SD
|
A:MET364
|
4.5
|
95.9
|
1.0
|
CZ
|
A:PHE368
|
4.5
|
58.4
|
1.0
|
SD
|
A:MET334
|
4.5
|
52.4
|
1.0
|
C13
|
A:PLB502
|
4.6
|
70.5
|
1.0
|
CG
|
A:LEU330
|
4.6
|
59.4
|
1.0
|
C
|
A:MET364
|
4.8
|
77.1
|
1.0
|
CD
|
A:LYS367
|
4.8
|
73.2
|
1.0
|
O11
|
A:EEY501
|
4.9
|
88.5
|
1.0
|
CG1
|
A:VAL339
|
5.0
|
51.5
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 8zfq
Go back to
Chlorine Binding Sites List in 8zfq
Chlorine binding site 2 out
of 4 in the Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl502
b:92.4
occ:1.00
|
CL19
|
A:PLB502
|
0.0
|
92.4
|
1.0
|
C14
|
A:PLB502
|
1.8
|
77.5
|
1.0
|
C15
|
A:PLB502
|
2.7
|
78.2
|
1.0
|
O12
|
A:PLB502
|
2.7
|
69.3
|
1.0
|
C13
|
A:PLB502
|
2.8
|
70.5
|
1.0
|
C11
|
A:PLB502
|
3.1
|
70.2
|
1.0
|
CG
|
A:MET364
|
3.7
|
82.8
|
1.0
|
C16
|
A:PLB502
|
4.0
|
68.9
|
1.0
|
CG2
|
A:ILE281
|
4.0
|
85.2
|
1.0
|
C18
|
A:PLB502
|
4.1
|
69.4
|
1.0
|
CD1
|
A:LEU353
|
4.1
|
64.7
|
1.0
|
CD2
|
A:LEU353
|
4.2
|
70.5
|
1.0
|
SG
|
A:CYS285
|
4.2
|
68.2
|
1.0
|
SD
|
A:MET364
|
4.2
|
95.9
|
1.0
|
CB
|
A:CYS285
|
4.3
|
68.7
|
1.0
|
N10
|
A:PLB502
|
4.5
|
67.6
|
1.0
|
C17
|
A:PLB502
|
4.6
|
71.6
|
1.0
|
CG
|
A:LEU353
|
4.8
|
61.1
|
1.0
|
CB
|
A:MET364
|
4.8
|
80.8
|
1.0
|
CE
|
A:MET364
|
4.9
|
77.2
|
1.0
|
C3
|
A:PLB502
|
5.0
|
67.8
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 8zfq
Go back to
Chlorine Binding Sites List in 8zfq
Chlorine binding site 3 out
of 4 in the Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl502
b:83.2
occ:1.00
|
CL20
|
B:PLB502
|
0.0
|
83.2
|
1.0
|
C16
|
B:PLB502
|
1.8
|
67.4
|
1.0
|
C15
|
B:PLB502
|
2.7
|
72.3
|
1.0
|
C17
|
B:PLB502
|
2.8
|
68.1
|
1.0
|
CE
|
B:MET334
|
3.2
|
58.6
|
1.0
|
CB
|
B:MET364
|
3.6
|
81.8
|
1.0
|
CB
|
B:LYS367
|
3.7
|
58.8
|
1.0
|
C14
|
B:PLB502
|
3.9
|
70.1
|
1.0
|
CD
|
B:LYS367
|
4.0
|
78.2
|
1.0
|
C18
|
B:PLB502
|
4.0
|
62.0
|
1.0
|
O
|
B:MET364
|
4.1
|
75.5
|
1.0
|
CD2
|
B:LEU330
|
4.1
|
62.9
|
1.0
|
SD
|
B:MET364
|
4.2
|
94.1
|
1.0
|
CG
|
B:MET364
|
4.3
|
85.2
|
1.0
|
SD
|
B:MET334
|
4.3
|
53.3
|
1.0
|
CG
|
B:LYS367
|
4.4
|
74.2
|
1.0
|
CG
|
B:LEU330
|
4.4
|
60.8
|
1.0
|
CA
|
B:MET364
|
4.4
|
82.5
|
1.0
|
C13
|
B:PLB502
|
4.5
|
63.8
|
1.0
|
CE2
|
B:PHE368
|
4.6
|
63.0
|
1.0
|
CD2
|
B:PHE368
|
4.7
|
65.3
|
1.0
|
C
|
B:MET364
|
4.7
|
79.9
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 8zfq
Go back to
Chlorine Binding Sites List in 8zfq
Chlorine binding site 4 out
of 4 in the Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of Human Ppargamma Ligand Binding Domain in Complex with T0070907 and Bvt.13 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl502
b:87.1
occ:1.00
|
CL19
|
B:PLB502
|
0.0
|
87.1
|
1.0
|
C14
|
B:PLB502
|
1.8
|
70.1
|
1.0
|
C13
|
B:PLB502
|
2.7
|
63.8
|
1.0
|
C15
|
B:PLB502
|
2.7
|
72.3
|
1.0
|
C11
|
B:PLB502
|
2.9
|
66.7
|
1.0
|
O12
|
B:PLB502
|
3.0
|
68.9
|
1.0
|
N10
|
B:PLB502
|
3.7
|
62.6
|
1.0
|
CG
|
B:MET364
|
3.9
|
85.2
|
1.0
|
CG2
|
B:ILE281
|
4.0
|
57.2
|
1.0
|
C16
|
B:PLB502
|
4.0
|
67.4
|
1.0
|
CE
|
B:MET364
|
4.0
|
83.2
|
1.0
|
C18
|
B:PLB502
|
4.0
|
62.0
|
1.0
|
SG
|
B:CYS285
|
4.1
|
74.0
|
1.0
|
C3
|
B:PLB502
|
4.1
|
63.6
|
1.0
|
CB
|
B:CYS285
|
4.2
|
65.3
|
1.0
|
CD2
|
B:LEU353
|
4.2
|
53.6
|
1.0
|
SD
|
B:MET364
|
4.2
|
94.1
|
1.0
|
O
|
B:HOH617
|
4.3
|
62.0
|
1.0
|
C2
|
B:PLB502
|
4.5
|
56.6
|
1.0
|
C17
|
B:PLB502
|
4.5
|
68.1
|
1.0
|
O
|
B:ILE281
|
4.8
|
59.4
|
1.0
|
CD1
|
B:LEU353
|
4.8
|
59.4
|
1.0
|
CB
|
B:MET364
|
4.9
|
81.8
|
1.0
|
|
Reference:
J.Shang,
D.J.Kojetin.
Unanticipated Mechanisms of Covalent Inhibitor and Synthetic Ligand Cobinding to Ppar Gamma. Elife 2024.
ISSN: ESSN 2050-084X
DOI: 10.7554/ELIFE.99782.1
Page generated: Sun Aug 11 10:56:47 2024
|